title: Four quadrant sclerotomies for uveal effusion syndrome.
authors.affiliation: Royal Victorian Eye and Ear Hospital, East Melbourne, VIC, Australia.
authors.forename: B Z
authors.initials: BZ
authors.lastname: Wang
authors.affiliation: Royal Victorian Eye and Ear Hospital, East Melbourne, VIC, Australia.
authors.forename: B
authors.initials: B
authors.lastname: Clark
authors.affiliation: Department of Histopathology, St Vincent's Hospital, Fitzroy, VIC, Australia.
authors.forename: P
authors.initials: P
authors.lastname: McKelvie
authors.affiliation: Royal Victorian Eye and Ear Hospital, East Melbourne, VIC, Australia.
authors.forename: B J
authors.initials: BJ
authors.lastname: Matthews
authors.affiliation: Royal Victorian Eye and Ear Hospital, East Melbourne, VIC, Australia.
authors.forename: R G
authors.initials: RG
authors.lastname: Buttery
authors.affiliation: Royal Victorian Eye and Ear Hospital, East Melbourne, VIC, Australia.
authors.forename: A
authors.initials: A
authors.lastname: Chandra
mesh_terms: D000086:Acetazolamide / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use*; D015862:Choroid Diseases / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D011461:Prostaglandins F, Synthetic / Q000627:therapeutic use*; D012163:Retinal Detachment / Q000188:drug therapy*; D014603:Uveal Diseases / Q000188:drug therapy*
chemical_list: D000959:Antihypertensive Agents; D002257:Carbonic Anhydrase Inhibitors; D011461:Prostaglandins F, Synthetic; D000086:Acetazolamide